Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Assets (2020 - 2025)

Biofrontera has reported Assets over the past 6 years, most recently at $28.6 million for Q4 2025.

  • For Q4 2025, Assets rose 29.24% year-over-year to $28.6 million; the TTM value through Dec 2025 reached $28.6 million, up 29.24%, while the annual FY2025 figure was $28.6 million, 29.24% up from the prior year.
  • Assets for Q4 2025 was $28.6 million at Biofrontera, up from $15.4 million in the prior quarter.
  • Over five years, Assets peaked at $55.1 million in Q3 2022 and troughed at $15.4 million in Q3 2021.
  • A 5-year average of $32.3 million and a median of $27.9 million in 2023 define the central range for Assets.
  • Biggest five-year swings in Assets: skyrocketed 258.6% in 2022 and later tumbled 45.71% in 2024.
  • Year by year, Assets stood at $53.2 million in 2021, then decreased by 4.39% to $50.9 million in 2022, then crashed by 45.11% to $27.9 million in 2023, then dropped by 20.88% to $22.1 million in 2024, then rose by 29.24% to $28.6 million in 2025.
  • Business Quant data shows Assets for BFRI at $28.6 million in Q4 2025, $15.4 million in Q3 2025, and $20.1 million in Q2 2025.